Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban.
Beyer
Jan
J
Division of Vascular Medicine, Department of Medicine 3, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. jan.beyer@uniklinikum-dresden.de
Halbritter
Kai
K
Weise
Matthias
M
Leonhard
Johannes
J
Schellong
Sebastian
S
D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives; D001780:Blood Coagulation Tests; D005121:Extremities / Q000473:pathology; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007511:Ischemia; D010875:Pipecolic Acids / Q000627:therapeutic use*; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; D014568:Urokinase-Type Plasminogen Activator; C031942:argatroban